- Home
- Publications
- Publication Search
- Publication Details
Title
Gastric biomarkers: a global review
Authors
Keywords
Gastric cancer, Biomarkers, Therapy
Journal
World Journal of Surgical Oncology
Volume 14, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-08-11
DOI
10.1186/s12957-016-0969-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2015
- (2015) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Long noncoding RNAs: Novel insights into gastric cancer
- (2015) Xin-yu Fang et al. CANCER LETTERS
- Relationship between PD-L1 expression and clinical outcomes in patients (Pts) with advanced gastric cancer treated with the anti-PD-1 monoclonal antibody pembrolizumab (Pembro; MK-3475) in KEYNOTE-012.
- (2015) Kei Muro et al. JOURNAL OF CLINICAL ONCOLOGY
- Prospective Comprehensive Genomic Profiling of Advanced Gastric Carcinoma Cases Reveals Frequent Clinically Relevant Genomic Alterations and New Routes for Targeted Therapies
- (2015) S. M. Ali et al. ONCOLOGIST
- Targeting the PI3K/Akt signaling pathway in gastric carcinoma: A reality for personalized medicine?
- (2015) Shikha Satendra Singh WORLD JOURNAL OF GASTROENTEROLOGY
- Molecular classification of gastric cancer: Towards a pathway-driven targeted therapy
- (2015) Ismael Riquelme et al. Oncotarget
- Abnormal Expression of E-Cadherin in Gastric Adenocarcinoma, and Its Correlation With Tumor Histopathology and Helicobacter Pylori Infection
- (2015) Robab Anbiaee et al. Iranian Red Crescent Medical Journal
- Plasma Post-operative miR-21 Expression in the Prognosis of Gastric Cancers
- (2014) Guo-Jian Ma et al. Asian Pacific Journal of Cancer Prevention
- Individual risk stratification of gastric cancer: Evolving concepts and their impact on clinical practice
- (2014) Massimo Rugge et al. BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
- A critical review of HER2-positive gastric cancer evaluation and treatment: From trastuzumab, and beyond
- (2014) Carlos Gomez-Martín et al. CANCER LETTERS
- Advances in molecular biomarkers for gastric cancer: miRNAs as emerging novel cancer markers
- (2014) Hua-Hsi Wu et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- MicroRNA-29c mediates initiation of gastric carcinogenesis by directly targeting ITGB1
- (2014) Tae-Su Han et al. GUT
- Lapatinib Plus Paclitaxel Versus Paclitaxel Alone in the Second-Line Treatment ofHER2-Amplified Advanced Gastric Cancer in Asian Populations: TyTAN—A Randomized, Phase III Study
- (2014) Taroh Satoh et al. JOURNAL OF CLINICAL ONCOLOGY
- Comprehensive molecular characterization of gastric adenocarcinoma
- (2014) Adam J. Bass et al. NATURE
- MT1-MMP is not a good prognosticator of cancer survival: evidence from 11 studies
- (2014) Kun-peng Wu et al. TUMOR BIOLOGY
- Matrix metalloproteinase-7 mRNA and protein expression in gastric carcinoma: a meta-analysis
- (2014) Zi-Wen Long et al. TUMOR BIOLOGY
- Diagnostic and prognostic value of circulating miR-18a in the plasma of patients with gastric cancer
- (2014) Zhong-Xue Su et al. TUMOR BIOLOGY
- Biomarkers for gastric cancer: prognostic, predictive or targets of therapy?
- (2014) Cecília Durães et al. VIRCHOWS ARCHIV
- Inflammation-related factors predicting prognosis of gastric cancer
- (2014) Wen-Jun Chang WORLD JOURNAL OF GASTROENTEROLOGY
- MicroRNAs as potential biomarkers for gastric cancer
- (2014) Han-Shao Liu WORLD JOURNAL OF GASTROENTEROLOGY
- Causes and consequences of microsatellite instability in gastric carcinogenesis
- (2014) Sérgia Velho WORLD JOURNAL OF GASTROENTEROLOGY
- Non-coding RNAs and gastric cancer
- (2014) Pei-Fei Li WORLD JOURNAL OF GASTROENTEROLOGY
- A systematic review of microRNA expression profiling studies in human gastric cancer
- (2014) Sirjana Shrestha et al. Cancer Medicine
- Assessment of HER2 gene amplification in adenocarcinomas of the stomach or gastroesophageal junction in the INT-0116/SWOG9008 clinical trial
- (2013) M. A. Gordon et al. ANNALS OF ONCOLOGY
- Gene regulation by the act of long non-coding RNA transcription
- (2013) Aleksandra E Kornienko et al. BMC BIOLOGY
- Matrix Metalloproteinase-14 Is a Negative Prognostic Marker for Patients with Gastric Cancer
- (2013) Liang He et al. DIGESTIVE DISEASES AND SCIENCES
- Identification of Circulating MicroRNAs as Novel Potential Biomarkers for Gastric Cancer Detection: A Systematic Review and Meta-Analysis
- (2013) Xingya Zhu et al. DIGESTIVE DISEASES AND SCIENCES
- Evaluation of HER2-based biology in 1,006 cases of gastric cancer in a Japanese population
- (2013) Masaki Aizawa et al. Gastric Cancer
- Genetics/Genomics/Proteomics of Gastric Adenocarcinoma
- (2013) Dushant S. Uppal et al. GASTROENTEROLOGY CLINICS OF NORTH AMERICA
- Matrix metalloproteinases and their tissue inhibitors in gastric cancer as molecular markers
- (2013) ClaraL Sampieri et al. Journal of Cancer Research and Therapeutics
- miRNA27a Is a Biomarker for Predicting Chemosensitivity and Prognosis in Metastatic or Recurrent Gastric Cancer
- (2013) Dingzhi Huang et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Somatic Mutations and Deletions of the E-Cadherin Gene Predict Poor Survival of Patients With Gastric Cancer
- (2013) Giovanni Corso et al. JOURNAL OF CLINICAL ONCOLOGY
- Everolimus for Previously Treated Advanced Gastric Cancer: Results of the Randomized, Double-Blind, Phase III GRANITE-1 Study
- (2013) Atsushi Ohtsu et al. JOURNAL OF CLINICAL ONCOLOGY
- HER2 in resected gastric cancer: Is there prognostic value?
- (2013) Sarah B. Fisher et al. JOURNAL OF SURGICAL ONCOLOGY
- Combined features based on MT1-MMP expression, CD11b + immunocytes density and LNR predict clinical outcomes of gastric cancer
- (2013) Chun-Wei Peng et al. Journal of Translational Medicine
- Long non-coding RNA expression profile in human gastric cancer and its clinical significances
- (2013) Haojun Song et al. Journal of Translational Medicine
- Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phase 3 trial
- (2013) Tom Waddell et al. LANCET ONCOLOGY
- Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial
- (2013) Florian Lordick et al. LANCET ONCOLOGY
- Gastric cancer—molecular and clinical dimensions
- (2013) Roopma Wadhwa et al. Nature Reviews Clinical Oncology
- Significance of TFF3 protein and Her-2/neu status in patients with gastric adenocarcinoma
- (2013) Cong-cong Xu et al. PATHOLOGY RESEARCH AND PRACTICE
- Long noncoding RNAs: fresh perspectives into the RNA world
- (2013) Lin Yang et al. TRENDS IN BIOCHEMICAL SCIENCES
- Prognosis of metastatic gastric and gastroesophageal junction cancer by HER2 status: a European and USA International collaborative analysis
- (2012) Y. Y. Janjigian et al. ANNALS OF ONCOLOGY
- Effect of HER2 on prognosis and benefit from peri-operative chemotherapy in early oesophago-gastric adenocarcinoma in the MAGIC trial
- (2012) A. F. C. Okines et al. ANNALS OF ONCOLOGY
- Her2/neu testing in gastric cancer: evaluating the risk of sampling errors
- (2012) V. S. Warneke et al. ANNALS OF ONCOLOGY
- Highly frequent PIK3CA amplification is associated with poor prognosis in gastric cancer
- (2012) Jing Shi et al. BMC CANCER
- Phase II study of everolimus with biomarker exploration in patients with advanced gastric cancer refractory to chemotherapy including fluoropyrimidine and platinum
- (2012) D H Yoon et al. BRITISH JOURNAL OF CANCER
- Increased signalling of EGFR and IGF1R and deregulation of PTEN/PI3K/Akt pathway are related with trastuzumab resistance in HER2 breast carcinomas
- (2012) A Gallardo et al. BRITISH JOURNAL OF CANCER
- MET in gastric carcinomas: comparison between protein expression and gene copy number and impact on clinical outcome
- (2012) H E Lee et al. BRITISH JOURNAL OF CANCER
- Impact of Expression of Human Epidermal Growth Factor Receptors EGFR and ERBB2 on Survival in Stage II/III Gastric Cancer
- (2012) M. Terashima et al. CLINICAL CANCER RESEARCH
- Second-generation irreversible epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs): A better mousetrap? A review of the clinical evidence
- (2012) Sai-Hong Ignatius Ou CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Clinicopathologic features and treatment outcomes of patients with human epidermal growth factor receptor 2-positive adenocarcinoma of the esophagus and gastroesophageal junction
- (2012) B. E. Phillips et al. DISEASES OF THE ESOPHAGUS
- E-cadherin dysfunction in gastric cancer - Cellular consequences, clinical applications and open questions
- (2012) Patrícia Carneiro et al. FEBS LETTERS
- HER2 expression and its clinicopathological features in resectable gastric cancer
- (2012) Yoshiki Kataoka et al. Gastric Cancer
- A comprehensive survey of genomic alterations in gastric cancer reveals systematic patterns of molecular exclusivity and co-occurrence among distinct therapeutic targets
- (2012) Niantao Deng et al. GUT
- Early HER2 dysregulation in gastric and oesophageal carcinogenesis
- (2012) Matteo Fassan et al. HISTOPATHOLOGY
- Meta-analysis of microRNA expression in lung cancer
- (2012) Urmo Võsa et al. INTERNATIONAL JOURNAL OF CANCER
- Alterations of theTP53Gene in Gastric and Esophageal Carcinogenesis
- (2012) Marilanda Ferreira Bellini et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Adverse Prognostic Impact of Intratumor Heterogeneous HER2 Gene Amplification in Patients With Esophageal Adenocarcinoma
- (2012) Harry H. Yoon et al. JOURNAL OF CLINICAL ONCOLOGY
- HER2/neutesting for anti-HER2-based therapies in patients with unresectable and/or metastatic gastric cancer
- (2012) Carlos Gómez-Martin et al. JOURNAL OF CLINICAL PATHOLOGY
- Discovery of biomarkers for gastric cancer: A proteomics approach
- (2012) Li-Ling Lin et al. Journal of Proteomics
- Increased MMP-21 expression is associated with poor overall survival of patients with gastric cancer
- (2012) Tao Wu et al. MEDICAL ONCOLOGY
- HER2 testing in gastric cancer: a practical approach
- (2012) Josef Rüschoff et al. MODERN PATHOLOGY
- Detection of kinase amplifications in gastric cancer archives using fluorescence in situ hybridization
- (2012) Shin-ichiro Kiyose et al. PATHOLOGY INTERNATIONAL
- High-Throughput Mutation Profiling Identifies Frequent Somatic Mutations in Advanced Gastric Adenocarcinoma
- (2012) Jeeyun Lee et al. PLoS One
- Alterations in the human epidermal growth factor receptor 2-phosphatidylinositol 3-kinase-v-Akt pathway in gastric cancer
- (2012) Yasutaka Sukawa WORLD JOURNAL OF GASTROENTEROLOGY
- Prognosis significance of HER-2/neu overexpression/amplification in Chinese patients with curatively resected gastric cancer after the ToGA clinical trial
- (2012) Fei Zhou et al. World Journal of Surgical Oncology
- Carcinoma of the stomach: A review of epidemiology, pathogenesis, molecular genetics and chemoprevention
- (2012) Siddavaram Nagini World Journal of Gastrointestinal Oncology
- The validation of matrix metalloproteinase-9 mRNA gene expression as a predictor of outcome in patients with metastatic gastric cancer
- (2011) S.-E. Al-Batran et al. ANNALS OF ONCOLOGY
- The role of the PD-1 pathway in autoimmunity and peripheral tolerance
- (2011) Brian T. Fife et al. Annals of the New York Academy of Sciences
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- MET Expression and Amplification in Patients with Localized Gastric Cancer
- (2011) Y. Y. Janjigian et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Non-coding RNAs as regulators of gene expression and epigenetics
- (2011) M. U. Kaikkonen et al. CARDIOVASCULAR RESEARCH
- A ceRNA Hypothesis: The Rosetta Stone of a Hidden RNA Language?
- (2011) Leonardo Salmena et al. CELL
- Intratumoral Heterogeneity Determines Discordant Results of Diagnostic Tests for Human Epidermal Growth Factor Receptor (HER) 2 in Gastric Cancer Specimens
- (2011) Jiyuan Yang et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- HER2 status in gastro-oesophageal adenocarcinomas assessed by two rabbit monoclonal antibodies (SP3 and 4B5) and two in situ hybridization methods (FISH and SISH)
- (2011) James E. Boers et al. HISTOPATHOLOGY
- Heterogeneous amplification of ERBB2 in primary lesions is responsible for the discordant ERBB2 status of primary and metastatic lesions in gastric carcinoma
- (2011) Min A Kim et al. HISTOPATHOLOGY
- Clinicopathologic factors associated with HER2-positive gastric cancer and its impact on survival outcomes-A systematic review
- (2011) Terence C. Chua et al. INTERNATIONAL JOURNAL OF CANCER
- Genetic Activation of theMETPathway and Prognosis of Patients With High-Risk, Radically Resected Gastric Cancer
- (2011) Francesco Graziano et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic or Predictive? It's Time to Get Back to Definitions!
- (2011) Antoine Italiano JOURNAL OF CLINICAL ONCOLOGY
- METAmplification Identifies a Small and Aggressive Subgroup of Esophagogastric Adenocarcinoma With Evidence of Responsiveness to Crizotinib
- (2011) Jochen K. Lennerz et al. JOURNAL OF CLINICAL ONCOLOGY
- Dual-colour HER2/Chromosome 17 chromogenic in situ hybridisation assay enables accurate assessment of HER2 genomic status in gastric cancer and has potential utility in HER2 testing of biopsy samples
- (2011) B. Yan et al. JOURNAL OF CLINICAL PATHOLOGY
- Evaluating the Consistency of Differential Expression of MicroRNA Detected in Human Cancers
- (2011) X. Gong et al. MOLECULAR CANCER THERAPEUTICS
- Extracellular microRNA: A new source of biomarkers
- (2011) Alton Etheridge et al. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
- Molecular pathology of gastric cancer: Research and practice
- (2011) Wataru Yasui et al. PATHOLOGY RESEARCH AND PRACTICE
- Familial Gastric Cancer: Genetics, Diagnosis, and Management
- (2011) Vanessa R. Blair Surgical Oncology Clinics of North America
- Clinicopathologic significance of HER-2/neu protein expression and gene amplification in gastric carcinoma
- (2011) Shi-Yan Yan WORLD JOURNAL OF GASTROENTEROLOGY
- Genomic and genetic alterations influence the progression of gastric cancer
- (2011) Stefania Nobili WORLD JOURNAL OF GASTROENTEROLOGY
- Low frequency of HER2 amplification and overexpression in early onset gastric cancer
- (2011) Cathy B. Moelans et al. CELLULAR ONCOLOGY
- HER2 Expression in Gastric and Gastroesophageal Junction Adenocarcinoma in a US Population
- (2011) Pamela L. Kunz et al. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
- Activated mammalian target of rapamycin is a potential therapeutic target in gastric cancer
- (2010) Da-zhi Xu et al. BMC CANCER
- Advanced gastric cancer – Slow but steady progress
- (2010) Derek G. Power et al. CANCER TREATMENT REVIEWS
- Trastuzumab in gastric cancer
- (2010) Alicia F.C. Okines et al. EUROPEAN JOURNAL OF CANCER
- E-cadherin genetic screening and clinico-pathologic characteristics of early onset gastric cancer
- (2010) Giovanni Corso et al. EUROPEAN JOURNAL OF CANCER
- Oncogenic mutations in gastric cancer with microsatellite instability
- (2010) Giovanni Corso et al. EUROPEAN JOURNAL OF CANCER
- Matrix metalloproteinase-9 is associated with disease-free survival and overall survival in patients with gastric cancer
- (2010) Dake Chu et al. INTERNATIONAL JOURNAL OF CANCER
- Multicenter Phase II Study of Everolimus in Patients With Previously Treated Metastatic Gastric Cancer
- (2010) Toshihiko Doi et al. JOURNAL OF CLINICAL ONCOLOGY
- A study of HER2 gene amplification and protein expression in gastric cancer
- (2010) B. Yan et al. JOURNAL OF CLINICAL PATHOLOGY
- The analysis of PIK3CA mutations in gastric carcinoma and metanalysis of literature suggest that exon-selectivity is a signature of cancer type
- (2010) Stefano Barbi et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Matrix metalloproteinases in health and disease: regulation by melatonin
- (2010) Snehasikta Swarnakar et al. JOURNAL OF PINEAL RESEARCH
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
- (2010) Yung-Jue Bang et al. LANCET
- MMP-7 overexpression is an independent prognostic marker in gastric cancer
- (2010) Selja Koskensalo et al. TUMOR BIOLOGY
- Correlation of Microsatellite Instability at Multiple Loci With Long-term Survival in Advanced Gastric Carcinoma
- (2009) Giovanni Corso ARCHIVES OF SURGERY
- Association of ERBB2 gene status with histopathological parameters and disease-specific survival in gastric carcinoma patients
- (2009) J D Barros-Silva et al. BRITISH JOURNAL OF CANCER
- Overexpression of Phosphorylated Mammalian Target of Rapamycin Predicts Lymph Node Metastasis and Prognosis of Chinese Patients with Gastric Cancer
- (2009) G. Yu et al. CLINICAL CANCER RESEARCH
- The Difference in p53 Mutations between Cancers of the Upper and Lower Gastrointestinal Tract
- (2009) Eiji Oki et al. DIGESTION
- Evidence of tumor microsatellite instability in gastric cancer with familial aggregation
- (2009) Corrado Pedrazzani et al. Familial Cancer
- Quantification of Epigenetic and Genetic 2nd Hits in CDH1 During Hereditary Diffuse Gastric Cancer Syndrome Progression
- (2009) Carla Oliveira et al. GASTROENTEROLOGY
- Germline CDH1 deletions in hereditary diffuse gastric cancer families
- (2009) C. Oliveira et al. HUMAN MOLECULAR GENETICS
- Allele-specific CDH1 downregulation and hereditary diffuse gastric cancer
- (2009) H. Pinheiro et al. HUMAN MOLECULAR GENETICS
- HER-2 amplification is highly homogenous in gastric cancer
- (2009) Andreas H. Marx et al. HUMAN PATHOLOGY
- HER-2 amplification is highly homogenous in gastric cancer
- (2009) Michael Bilous et al. HUMAN PATHOLOGY
- Gastric cancer
- (2009) Henk H Hartgrink et al. LANCET
- Involvement of the HER2 pathway in repair of DNA damage produced by chemotherapeutic agents
- (2009) J. J.M. Boone et al. MOLECULAR CANCER THERAPEUTICS
- The Origins and Evolution of the p53 Family of Genes
- (2009) V. A. Belyi et al. Cold Spring Harbor Perspectives in Biology
- Prognosis of pN3 Stage Gastric Cancer
- (2009) Jung Ryun Ahn et al. Cancer Research and Treatment
- HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target
- (2008) C. Gravalos et al. ANNALS OF ONCOLOGY
- Biomarkers of response to therapy in oesophago-gastric cancer
- (2008) K R Fareed et al. GUT
- EGFR in gastric carcinomas: prognostic significance of protein overexpression and high gene copy number
- (2008) M A Kim et al. HISTOPATHOLOGY
- Chemotherapy for metastatic gastric cancer: past, present, and future
- (2008) Atsushi Ohtsu JOURNAL OF GASTROENTEROLOGY
- Mechanisms and sequelae of E-cadherin silencing in hereditary diffuse gastric cancer
- (2008) M Barber et al. JOURNAL OF PATHOLOGY
- Serum MicroRNAs Are Promising Novel Biomarkers
- (2008) Shlomit Gilad et al. PLoS One
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now